Marc Beer is a man who turned a terrible loss into a rewarding business. When his wife passed away, he got a phone call from a gynecologist asking for advice on how to save women who had pelvic floor problems from having surgeries. After that phone call, Mr. Beer decided to create a company called Renovia. He also became the CEO and chairman of the company. Renovia provides diagnostic and analeptic gadgets for women who have issues with their pelvic floor. Those issues can be urinary incontinence, pelvic organ prolapse, and fecal incontinence. Last year, Renovia developed Leva which had the FDA seal of approval back in April. With the products from Renovia, women can manage their pelvic issues and recover the strength of their pelvic muscles.
Last month, Marc Beer became the chairman of a company called LumeNXT. LumeNXT is a biomedical company that constructs surgical instruments. Mr. Beer has high hopes with the safe instruments that LumeNXT makes. He thinks that with these new instruments, there will more minimally invasive surgeries in the future.
Marc Beer didn’t start his journey as a chairman of two companies and a CEO. He began in pharmaceutical sales and marketing at Abbott Laboratories. Then he became the Vice President of Global Marketing at Genzyme. Mr. Beer helped people around the world who had rare diseases by avocating Genzyme’s products. In 2000, he created his first company called ViaCell. ViaCell is a biotech company that houses umbilical cord blood stem cells. With Mr. Beer’s leadership, ViaCell grew to have 300 employees and making the NASDAQ list in 2005. In 2007, he sold the company to PerkinElmer. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
In 1987, Mr. Beer acquired a Bachelor of Science in Business degree at Miami University. He also serves as a member of the Notre Dame Research and Commercialization Advisory Committee and the Graduate Studies Research and Advisory Council. He is also a member of the Miami University Business Advisory Council. Mr. Beer was a member of the Mass Life Science Board for the Commonwealth of Massachusetts and the Biotechnology Innovation Organization (BIO) Emerging Companies Section Governing Board. He also served as a member of the board of directors at Erytech Pharma. Mr. Beer is the founding Chairman of the board, chairman of the compensation committee and member of the audit committee of Minerva Neurosciences Inc. Mr. Beer also was on the board of directors of the Joe Andruzzi Cancer Foundation.